Plant Health Care (PHC) Share Price, News & Analysis

Company Overview

Plant Health Care plc, together with its subsidiaries, provides agricultural biological products and technology solutions in the Americas, Mexico, and internationally. It offers products to enhance the yield and quality of crops, such as corn, soybeans, sugar cane, citrus, and rice, as well as fruits and vegetables. The company provides Harpin aß, a recombinant protein, which acts as a biostimulant to enhance the yield and quality of crops; and Saori, a vaccine for plants that promotes healthy growth of soybeans and helps them fight disease. It also distributes third-party biological products. The company was founded in 1995 and is headquartered in Holly Springs, North Carolina.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: 1.00 million shs
• Average Volume: 865,642 shs
• Market Capitalization: £32.50 million
• P/E Ratio: N/A
• Dividend Yield: 1.41%
• Price Target: N/A
• Consensus Rating: N/A

PHC Stock Analysis - Frequently Asked Questions

How do I buy shares of Plant Health Care?

Shares of PHC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Plant Health Care own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Plant Health Care investors own include Coats Group (COA), Glencore (GLEN), Synopsys (SNPS), Standard Chartered (STAN), AutoZone (AZO), Bank of America (BAC) and Barclays (BARC).

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Basic Materials
• Industry: Agricultural Inputs
• Sub-Industry: N/A
• Current Symbol: LON:PHC
• CIK: N/A
• Web: www.planthealthcare.com
• Phone: +1-919-9261600
• Fax: N/A
• Employees: 56
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): GBX (0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -£4 million
• Net Margins: -35.69%
• Pretax Margin: N/A
• Return on Equity: -40.17%
• Return on Assets: -20.92%

Debt

• Debt-to-Equity Ratio: 11.32
• Current Ratio: 3.04
• Quick Ratio: 2.69

Sales & Book Value

• Annual Sales: £11.21 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: 4.66
• Book Value: GBX 3 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 364,100,000
• Free Float: N/A
• Market Cap: £32.50 million
• Optionable: Not Optionable
• Beta: 0.81